Cargando…

Users’ acceptance of electronic patient portals in Lebanon

BACKGROUND: Acceptance of Electronic patient portal (EPP) is instrumental for its success. Studies on users’ acceptance in the Middle East region are scarce. This study aims to use the TAM as a framework to quantitatively describe potential users, diabetic and chronic high blood pressure patients an...

Descripción completa

Detalles Bibliográficos
Autores principales: Honein-AbouHaidar, Gladys N., Antoun, Jumana, Badr, Karim, Hlais, Sani, Nazaretian, Houry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027116/
https://www.ncbi.nlm.nih.gov/pubmed/32066425
http://dx.doi.org/10.1186/s12911-020-1047-x
_version_ 1783498803851034624
author Honein-AbouHaidar, Gladys N.
Antoun, Jumana
Badr, Karim
Hlais, Sani
Nazaretian, Houry
author_facet Honein-AbouHaidar, Gladys N.
Antoun, Jumana
Badr, Karim
Hlais, Sani
Nazaretian, Houry
author_sort Honein-AbouHaidar, Gladys N.
collection PubMed
description BACKGROUND: Acceptance of Electronic patient portal (EPP) is instrumental for its success. Studies on users’ acceptance in the Middle East region are scarce. This study aims to use the TAM as a framework to quantitatively describe potential users, diabetic and chronic high blood pressure patients and their providers, intention to use and factors influencing the intention to use EPP at AUBMC-FMC We concurrently test the internal construct validity and the reliability of the TAM. METHODS: A cross-sectional survey design and the vignette approach were used. For validation, we needed a minimum of 180 patients; all 35 attending physicians and 11 registered nurses were targeted. We used descriptive statistics to calculate the intention to use EPP and its determinants based on the TAM constructs. Exploratory factor analysis (EFA) and structural equation modeling (SEM) were employed to estimate significant path coefficients for patients only as the sample size of providers was too small. RESULTS: We had 199 patients, half intended to use EPP; 73% of providers (N = 17) intended to use EPP. Perceived ease of use and privacy concerns were significantly higher among providers than patients (Mean (M) = 0.77 vs M = 0.42 (CI: − 0.623; − 0.081)) and (M = 3.67 vs M = 2.13, CI: − 2.16; − 0.91) respectively; other constructs were not significantly different. Reliability of TAM revealed a Cronbach Alpha of α=.91. EFA showed that three components explained 73.48% of the variance: Behavioral Intention of Use (14.9%), Perceived Ease of Use (50.74%), Perceived Usefulness (7.84%). SEM found that perceived ease of use increased perceived usefulness (standardized regression weight = 0.49); perceived usefulness (0.51) had more predictive value than perceived ease of use (0.27) to explain the behavioral intention of use of the EPP. CONCLUSIONS: We found that providers valued the usefulness of EPP and were mostly intending to use it. This finding has yet to be tested in future studies testing actual use as intention and actual use may not be concordant. The intention to use among patients was lower than those reported in developed countries. We identified two factors that we need to address to increase use, namely perceived ease and usefulness, and proposed practical implications to address them; future research directions were also discussed.
format Online
Article
Text
id pubmed-7027116
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-70271162020-02-24 Users’ acceptance of electronic patient portals in Lebanon Honein-AbouHaidar, Gladys N. Antoun, Jumana Badr, Karim Hlais, Sani Nazaretian, Houry BMC Med Inform Decis Mak Research Article BACKGROUND: Acceptance of Electronic patient portal (EPP) is instrumental for its success. Studies on users’ acceptance in the Middle East region are scarce. This study aims to use the TAM as a framework to quantitatively describe potential users, diabetic and chronic high blood pressure patients and their providers, intention to use and factors influencing the intention to use EPP at AUBMC-FMC We concurrently test the internal construct validity and the reliability of the TAM. METHODS: A cross-sectional survey design and the vignette approach were used. For validation, we needed a minimum of 180 patients; all 35 attending physicians and 11 registered nurses were targeted. We used descriptive statistics to calculate the intention to use EPP and its determinants based on the TAM constructs. Exploratory factor analysis (EFA) and structural equation modeling (SEM) were employed to estimate significant path coefficients for patients only as the sample size of providers was too small. RESULTS: We had 199 patients, half intended to use EPP; 73% of providers (N = 17) intended to use EPP. Perceived ease of use and privacy concerns were significantly higher among providers than patients (Mean (M) = 0.77 vs M = 0.42 (CI: − 0.623; − 0.081)) and (M = 3.67 vs M = 2.13, CI: − 2.16; − 0.91) respectively; other constructs were not significantly different. Reliability of TAM revealed a Cronbach Alpha of α=.91. EFA showed that three components explained 73.48% of the variance: Behavioral Intention of Use (14.9%), Perceived Ease of Use (50.74%), Perceived Usefulness (7.84%). SEM found that perceived ease of use increased perceived usefulness (standardized regression weight = 0.49); perceived usefulness (0.51) had more predictive value than perceived ease of use (0.27) to explain the behavioral intention of use of the EPP. CONCLUSIONS: We found that providers valued the usefulness of EPP and were mostly intending to use it. This finding has yet to be tested in future studies testing actual use as intention and actual use may not be concordant. The intention to use among patients was lower than those reported in developed countries. We identified two factors that we need to address to increase use, namely perceived ease and usefulness, and proposed practical implications to address them; future research directions were also discussed. BioMed Central 2020-02-17 /pmc/articles/PMC7027116/ /pubmed/32066425 http://dx.doi.org/10.1186/s12911-020-1047-x Text en © The Author(s). 2020 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Honein-AbouHaidar, Gladys N.
Antoun, Jumana
Badr, Karim
Hlais, Sani
Nazaretian, Houry
Users’ acceptance of electronic patient portals in Lebanon
title Users’ acceptance of electronic patient portals in Lebanon
title_full Users’ acceptance of electronic patient portals in Lebanon
title_fullStr Users’ acceptance of electronic patient portals in Lebanon
title_full_unstemmed Users’ acceptance of electronic patient portals in Lebanon
title_short Users’ acceptance of electronic patient portals in Lebanon
title_sort users’ acceptance of electronic patient portals in lebanon
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027116/
https://www.ncbi.nlm.nih.gov/pubmed/32066425
http://dx.doi.org/10.1186/s12911-020-1047-x
work_keys_str_mv AT honeinabouhaidargladysn usersacceptanceofelectronicpatientportalsinlebanon
AT antounjumana usersacceptanceofelectronicpatientportalsinlebanon
AT badrkarim usersacceptanceofelectronicpatientportalsinlebanon
AT hlaissani usersacceptanceofelectronicpatientportalsinlebanon
AT nazaretianhoury usersacceptanceofelectronicpatientportalsinlebanon